- Home
- BLFS vs BCRX Comparison
BLFS vs BCRX Comparison
Compare BLFS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- BCRX
- Stock Information
- Founded
- BLFS 1987
- BCRX 1986
- Country
- BLFS United States
- BCRX United States
- Employees
- BLFS N/A
- BCRX N/A
- Industry
- BLFS Medical/Dental Instruments
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLFS Health Care
- BCRX Health Care
- Exchange
- BLFS Nasdaq
- BCRX Nasdaq
- Market Cap
- BLFS 1.3B
- BCRX 1.4B
- IPO Year
- BLFS 1989
- BCRX 1994
- Fundamental
- Price
- BLFS $27.98
- BCRX $7.24
- Analyst Decision
- BLFS Strong Buy
- BCRX Strong Buy
- Analyst Count
- BLFS 7
- BCRX 11
- Target Price
- BLFS $30.86
- BCRX $19.55
- AVG Volume (30 Days)
- BLFS 366.2K
- BCRX 7.1M
- Earning Date
- BLFS 11-06-2025
- BCRX 11-03-2025
- Dividend Yield
- BLFS N/A
- BCRX N/A
- EPS Growth
- BLFS N/A
- BCRX N/A
- EPS
- BLFS N/A
- BCRX N/A
- Revenue
- BLFS $93,468,000.00
- BCRX $557,506,000.00
- Revenue This Year
- BLFS $25.65
- BCRX $41.57
- Revenue Next Year
- BLFS $14.81
- BCRX $6.25
- P/E Ratio
- BLFS N/A
- BCRX N/A
- Revenue Growth
- BLFS 68.16
- BCRX 45.85
- 52 Week Low
- BLFS $19.10
- BCRX $6.00
- 52 Week High
- BLFS $29.62
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- BLFS 57.01
- BCRX 49.27
- Support Level
- BLFS $26.74
- BCRX $6.44
- Resistance Level
- BLFS $29.57
- BCRX $6.92
- Average True Range (ATR)
- BLFS 1.03
- BCRX 0.30
- MACD
- BLFS 0.00
- BCRX 0.08
- Stochastic Oscillator
- BLFS 55.34
- BCRX 92.54
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.